【 KCI 】Comparison of Cryotop and ReproCarreir products for cryopreservation of bovine blastocysts through survival rate and blastocysts quality > 학술지 논문

본문 바로가기

사이트 내 전체검색

학술지 논문

국내논문 【 KCI 】Comparison of Cryotop and ReproCarreir products for cryopreserv…

페이지 정보

작성자 최고관리자 작성일 20-10-16 18:18 조회 248회 댓글 0건

본문

 TITLE Comparison of Cryotop and ReproCarreir products for cryopreservation of bovine blastocysts through survival rate and blastocysts quality

 

JOURNAL Journal of Animal Reproduction and Biotechnology (JARB)

 NAME  Jin-Woo Kim, Seul-Gi Yang, Hyo-Jin Park, Ju Hwan Kim, Dong-Mok Lee, Seong-Min Woo, Hyun-Jeong Kim, Hyun Ah Kim, Jae-Hoon Jeong, Min Ji Lee and Deog-Bon Koo

 PUBLISHED 30 June 2020

 ISSN 2671-4663

DOI https://doi.org/10.12750/JARB.35.2.207

 

 ABSTRACT 

 Cryopreservation is used for blastocyst preservation of most mammalian embryos and is an important technique for breeding. We aimed to compare the efficiency of the cryopreservation method using the standard Cryotop device and the ReproCarrier device, a domestic product manufactured in Korea. The efficacy of the two devices was analyzed based on the survival rate, intracellular levels of reactive oxygen species (ROS), and apoptosis of the vitrified bovine blastocysts. The survival rates of the vitrified-warmed blastocysts were similar between the ReproCarrier group (58.4 ± 17.7%) and Cryotop group (59.9 ± 14.1%). Intracellular ROS levels and apoptotic index were determined by DCFDA staining and TUNEL assay. Changes in intracellular ROS levels, number of total nuclei, and cellular apoptosis of vitrified blastocysts after cryopreservation were not significantly different between the two groups. These results indicate that the ReproCarrier device method is as effective as the standard Cryotop method for vitrification of bovine blastocysts in vitro.

 KEYWORDS bovine blastocyst, cryopreservation, Cryotop, ReproCarrier, vitrification

 
  • 트위터로 보내기
  • 페이스북으로 보내기
  • 구글플러스로 보내기

댓글목록

등록된 댓글이 없습니다.

Copyright © du-infertility.re.kr. All rights reserved.